Mirae Asset Global Investments Co., Ltd. Celldex Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $54.3 Billion
- Q1 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 25,779 shares of CLDX stock, worth $937,324. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,779
Previous 26,258
1.82%
Holding current value
$937,324
Previous $1.04 Million
3.84%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CLDX
# of Institutions
206Shares Held
61.2MCall Options Held
291KPut Options Held
246K-
Wellington Management Group LLP Boston, MA7.65MShares$278 Million0.06% of portfolio
-
Black Rock Inc. New York, NY4.51MShares$164 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.65MShares$133 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.12MShares$113 Million2.11% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$112 Million0.02% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.7B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...